| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 26.70▲ | 26.72▲ | 26.73▲ | 26.16▲ | 26.04▲ |
| MA10 | 26.70▲ | 26.69▲ | 26.55▲ | 25.59▲ | 27.44▼ |
| MA20 | 26.77▼ | 26.55▲ | 26.38▲ | 26.14▲ | 32.65▼ |
| MA50 | 26.57▲ | 26.10▲ | 25.63▲ | 27.44▼ | N/A |
| MA100 | 26.33▲ | 25.58▲ | 25.85▲ | 33.80▼ | N/A |
| MA200 | 25.87▲ | 25.98▲ | 26.88▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.018▼ | -0.004▼ | 0.008▲ | 0.250▲ | -0.742▼ |
| RSI | 55.233▲ | 59.218▲ | 61.427▲ | 49.968▼ | 36.813▼ |
| STOCH | 62.641 | 75.036 | 72.351 | 61.927 | 21.020 |
| WILL %R | -28.378 | -21.512▲ | -17.536▲ | -26.025 | -84.593▼ |
| CCI | 25.205 | 45.130 | 68.728 | 105.125▲ | -56.848 |
|
Wednesday, June 11, 2025 02:29 AM
Outlook Therapeutics, Inc. (Nasdaq: OTLK), today announced the Scottish Medicines Consortium (SMC) approval of LYTENAVA™ (bevacizumab gamma) for the treatment of wet age-related macular degeneration ...
|
|
Tuesday, June 10, 2025 05:05 AM
ISELIN, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment ...
|
|
Tuesday, June 10, 2025 05:05 AM
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the Scottish ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/06/25 | 26.845 | 26.975 | 26.50 | 26.765 | 25,951 |
| 13/06/25 | 26.42 | 26.88 | 26.00 | 26.29 | 57,000 |
| 12/06/25 | 25.82 | 26.85 | 25.82 | 26.11 | 57,900 |
| 11/06/25 | 25.67 | 26.34 | 25.34 | 26.22 | 54,100 |
| 10/06/25 | 25.235 | 25.60 | 24.97 | 25.435 | 62,556 |
| 09/06/25 | 25.43 | 25.48 | 24.475 | 24.80 | 69,891 |
| 06/06/25 | 24.63 | 25.16 | 24.58 | 25.05 | 42,800 |
| 05/06/25 | 25.24 | 25.285 | 24.42 | 24.54 | 41,503 |
| 04/06/25 | 25.74 | 26.2405 | 24.79 | 25.04 | 127,537 |
| 03/06/25 | 26.00 | 26.515 | 25.45 | 25.66 | 49,102 |
|
|
||||
|
|
||||
|
|